Measurement of absolute oxygen levels in cells and tissues using oxygen sensors and 2-nitroimidazole EF5

Methods in Enzymology

Volumn 352, Issue , 2002, Pages 3-31

  Koch, Cameron J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (1,1,1,3,3,3 HEXAFLUORO 2 PROPOXY) 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL; 1 FLUORO 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL; 2 (2 NITRO 1H IMIDAZOL 1 YL) N (2,2,3,3,3 PENTAFLUOROPROPYL)ACETAMIDE; 2 NITROIMIDAZOLE; ASCORBIC ACID; CYTOCHROME C OXIDASE; EF 3; ETANIDAZOLE; GLUCOSE; HETEROCYCLIC COMPOUND; MISONIDAZOLE; MONOCLONAL ANTIBODY; NITROGEN DERIVATIVE; OXYGEN; PIMONIDAZOLE; POLYACRYLAMIDE; THEOPHYLLINE; UNCLASSIFIED DRUG; 2-(2-NITRO-1H-IMIDAZOL-1-YL)-N-(2,2,3,3,3-PENTAFLUOROPROPYL)ACETAMIDE; DRUG DERIVATIVE; FLUORINATED HYDROCARBON;

ARTICLE; BINDING AFFINITY; BIOSENSOR; CELL CULTURE; CELL TYPE; COVALENT BOND; CULTURE MEDIUM; DRUG BINDING; DRUG DISTRIBUTION; DRUG METABOLISM; FILM; FLOW RATE; FLUORESCENCE ANALYSIS; GAS FLOW; HUMAN; HYPOXIA; IMMUNOHISTOCHEMISTRY; NONHUMAN; OXIMETRY; OXYGEN CONCENTRATION; OXYGEN DIFFUSION; OXYGEN TENSION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIATION DOSE; RADIOACTIVITY; TISSUE OXYGENATION; ANIMAL; ANOXIA; BIOCHEMISTRY; FLOW CYTOMETRY; METABOLISM; METHODOLOGY; MOUSE; NEOPLASM; PATHOLOGY; PRESSURE; REVIEW; TIME;

ANIMALS; ANOXIA; BIOCHEMISTRY; ETANIDAZOLE; FLOW CYTOMETRY; HUMANS; HYDROCARBONS, FLUORINATED; IMMUNOHISTOCHEMISTRY; MICE; NEOPLASMS; OXYGEN; PRESSURE; TIME FACTORS;

EID: 0036048395     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(02)52003-6     Document Type: Article

References (90)

1. J. D. Chapman, A. J. Franko, and C. J. Koch, in "Biological Bases and Clinical Implications of Tumor Radioresistance" (G. H. Fletcher, C. Nervi, and H. R. Withers, eds.), p. 61. Masson Pub., New York, NY, 1983.
2. J. E. Moulder and S. C. Rockwell, Int. J. Radiat. Oncol. Biol. Phys. 10, 695 (1984).
3. G. E. Adams, Cancer 48, 696 (1981).
4. K. A. Kennedy, B. A. Teicher, S. C. Rockwell, and A. C. Sartorelli, Biochem. Pharm. 29, 1 (1980).
5. J. M. Henk, Int. J. Radiat. Oncol. Biol. Phys. 12, 1339 (1986).
6. J. Overgaard, H. Hansen, A. P. Sandersen, M. Hjelm-Hansen, K. Jorgensen, E. Sandberg, A. Berthelsen, R. Hammer, and M. Pedersen, Int. J. Radiat. Oncol. Biol. Phys. 16, 1065 (1989).
7. J. Overgaard, Radiother. Oncol. 24, S64 (1992).
8. T. L. Phillips, T. H. Wasserman, R. J. Johnson, V. A. Levin, and G. VanRaalte, Cancer 48,1687 (1981).
9. R. C. Urtasun, C. N. Coleman, T. H. Wasserman, and T. L. Phillips, Int. J. Radiat. Oncol. Biol. Phys. 10, 1691 (1984).
10. H. B. Stone, J. M. Brown, T. L. Phillips, and R. M. Sutherland, Radiat. Res. 136, 422 (1993).
11. D. M. Brizel, G. L. Rosner, J. Harrelson, L. R. Prosnitz, and M. W. Dewhirst, Int. J. Radiat. Oncol. Biol. Phys. 30, 635 (1994).
12. P. Okunieff, M. Hockel, E. P. Dunphy, K. Schlenger, C. Knoop, and P. Vaupel, Int. J. Radiat. Biol. Oncol. Phys. 26, 631 (1993).
13. R. Rampling, G. Cruickshank, A. Lewis, S. A. Fitzsimmons, and P. Workman, Int. J. Radiat. Oncol. Biol. Phys. 29, 427 (1994).
14. D. M. Brizel, S. P. Scully, J. M. Harrelson, L. J. Layfield, J. M. Bean, L. R. Prosnitz, and M. W. Dewhirst, Cancer Res. 56, 941 (1996).
15. A. W. Fyles, M. Milosevic, R. Wong, M. C. Kavanagh, M. Pintilie, W. Chapman, W. Levin, L. Manchul, T. J. Keane, and R. P. Hill, Radiother. Oncol. 48, 149 (1998).
16. M. Hockel, C. Knoop, K. Schlenger, B. Vordran, E. Baussmann, M. Mitze, P. G. Knapstein, and P. Vaupel, Radiother. Oncol. 26, 45 (1993).
17. M. Nordsmark, M. Overgaard, and J. Overgaard, Radiother. Oncol. 41, 31 (1996).
18. D. B. Cater and I. A. Silver, Acta Radiol. 23, 233 (1942).
19. R. A. Gatenby, H. B. Kessler, J. S. Rosenblum, L. R. Coia, P. J. Moldofsky, W. H. Hartz, and G. J. Broder, Radiology 156, 211 (1985).
20. R. A. Gatenby, H. B. Kessler, J. S. Rosenblum, L. R. Coia, P. J. Moldofsky, W. H. Hartz, and G. J. Broder, Int. J. Radiat. Oncol. Biol. Phys. 14, 831 (1988).
21. P. Vaupel, P. Okunieff, F. Kallinowski, and L. J. Neuringer, Radiat. Res. 120, 477 (1989).
22. P. Wendling, R. Manz, G. Thews, and P. Vaupel, Adv. Exp. Med. Biol. 180, 293 (1984).
23. T. G. Graeber, C. Osmanian, T. Jacks, D. E. Housman, C. J. Koch, S. W. Lowe, and A. J. Giaccia, Nature 379, 88 (1996).
24. T. Y. Reynolds, S. Rockwell, and P. M. Glazer, Cancer Res. 56, 5754 (1990).
25. S. D. Young, R. S. Marshall, and R. P. Hill, Proc. Natl. Acad. Sci. U.S.A. 85, 9533 (1988).
26. E. Y. Chen, M. Fujinaga, and A. J. Giaccia, Teratology 60, 215 (1999).
27. R. I. Clyman, C. Y. Chan, F. Mauray, Y. Q. Chen, W. Cox, S. R. Seidner, H. Weiss, E. M. Lord, N. Waleh, S. M. Evans, and C. J. Koch, Pediatr. Res. 45, 19 (1999).
28. Adv. Exp. Mecl. Biol., published annually.
29. The solubility of gas is temperature dependent, as is the partial pressure due to water vapor. In this report, the following assumptions ale made regarding oxygen solubility. At 37°, the partial pressure of water vapor is ∼45 mm of Hg; thus, atmospheric pressure of 760 mm of Hg of air with saturated water vapor allows for oxygen (21%) + nitrogen (79%) partial pressures of 149 + 566 mm of Hg, respectively. The solubility of oxygen in physiological saline (or equivalent) equilibrated with water vapor-saturated air at 37° is about 0.20 mM. At 25° and 4°, the corresponding solubility is about 0.25 and 0.45 mM, respectively. In the text, we report absolute concentrations (in micromolar) and mm of Hg or percentage oxygen values assuming a temperature of 37°.
30. L. C. J. Clark, Trans. Am. Soc. Artif. Int. Organs 2, 41 (1956).
31. C. J. Koch, "Polarographic Oxygen Sensor with Glass Seal." Canada Patent, 1304449: June 30, 1992.
32. C. J. Koch and J. Kruuv, Anal. Chem. 44, 1258 (1972).
33. Polycarbonate is the most oxygen permeable of plastics made for tissue culture use (dishes are made by NUNC). The least toxic and water-impermeable tubing is made from silicone, but it is by far the worst in the sense of high oxygen permeability. It is not the present intention to make a blanket condemnation of experiments using plastics. Rather, it should be appreciated that many oxygen-dependent chemical and biological phenomena are very sensitive to the range of oxygen below 2% (some much lower still). Thus, use of plastics may prevent a proper understanding of the oxygen dependence of various biological phenomena.
34. J. D. Chapman, J. Sturrock, J. W. Boag, and J. O. Crookall, Int. J. Radiat. Biol. 17, 305 (1970).
35. C. J. Koch and J. Kruuv, Br. J. Radiol. 45, 787 (1972).
36. A. J. Franko, H. I. Freedman, and C. J. Koch, in "Spheroids in Cancer Research," p. 162. Springer Verlag, Berlin, 1984.
37. C. J. Koch, in "Proc. 6th L. H. Gray Conf. (1974)," p. 167. Institute of Physics, London, 1975.
38. To promote cell attachment, glass is cleaned, heated to 500°, and then conditioned by overnight treatment with water containing 50 mM sodium carbonate and 15% serum, followed by 1 hr with water containing tissue culture grade gelatin (0.1%). The gelatin is removed, but the thin remaining film is allowed to dry onto the glass under UV light in a sterile hood.
39. C. J. Koch, Radiat. Res. 97, 434 (1984).
40. C. J. Koch, Adv. Exp. Biol. Med. 157, 123 (1983).
41. L.-W. Lo, C. J. Koch, and D. F. Wilson, Anal. Biochem. 236, 153 (1996).
42. R. S. Marshall, C. J. Koch, and A. M. Rauth, Radiat. Res. 108, 91 (1986).
43. It is important to realize that the internal volume of gas regulators is several tens of milliliters. Thus, when a regulator is first connected to a gas cylinder (or pressurized after disuse), this internal oxygen-containing volume is highly pressurized by the cylinder gas (e.g., nitrogen) and can cause a long-lasting contamination of oxygen if used at low flow rates. To prevent this, the regulator must be purged by a series of on-off cycles of the high-pressure cylinder valve, each followed by release of the gas from the regulator.
44. D. G. Buerk, "Biosensors: Theory and Applications." Technomic, Lancaster, PA, 1993.
45. O. Thews, D. K. Kelleher, and P. W. Vaupel, in "Tumor Oxygenation," p. 27. Gustav Fisher Verlag, Stuttgart, Germany, 1995.
46. W. Mueller-Klieser, J. P. Freyer, and R. M. Sutherland, Br. J. Cancer 53, 345 (1986).
47. C. Y. Li, S. Shan, Q. Huang, R. D. Braun, J. Lanzen, K. Hu, P. Lin, and M. W. Dewhirst, J. Nat. Cancer Inst. 92, 143 (2000).
48. G. E. Adams, A. Breccia, E. M. Fielden, and E Wardman (eds.), "Selective Activation of Drugs by Redox Processes." Plenum Press, New York, 1990.
49. J. D. Chapman, K. A. Baer, and J. Lee, Cancer Res. 43, 1523 (1983).
50. Y. C. Taylor and A. M. Rauth, Cancer Res. 38, 2745 (1978).
51. A. J. Varghese, S. Gulyas, and J. K. Mohindra, Cancer Res. 36, 3761 (1976).
52. C. J. Koch and J. A. Raleigh, Arch. Biochem. Biophys. 287, 75 (1991).
53. J. A. Raleigh and C. J. Koch, Biochem. Pharmacol. 40, 2457 (1990).
54. A. J. Franko and C. J. Koch, Int. J. Radial. Oncol. Biol. Phys. 10, 1333 (1984).
55. A. J. Franko, C. J. Koch, B. M. Garrecht, J. Sharplin, and J. Howorko, Cancer Res. 47, 5367 (1987).
56. D. G. Hirst, J. L. Hazlehurst, and J. M. Brown, Int. J. Radial. Biol. Oncol. Phys. 11, 1349 (1984).
57. L. M. Cobb, J. Nolan, and P. O'Neill, Br. J. Cancer 59, 12 (1989).
58. L. M. Cobb, J. Nolan, and T. Hacker, Int. J. Radial. Oncol. Biol. Phys. 22, 655 (1992).
59. C. J. Koch, in "Selective Activation of Drugs by Redox Processes" (G. E. Adams, A. Breccia, E. M. Fielden, and P. Wardman, eds.), p. 237. Plenum Press, NY, 1990.
60. D. J. Van Os-Corby, C. J. Koch, and J. D. Chapman, Biochem. Pharmacol. 36, 3487 (1987).
61. B. M. Garrecht and J. D. Chapman, Br. J. Radiol. 56, 745 (1983).
62. R. C. Urtasun, C. J. Koch, A. J. Franko, J. A. Raleigh, and J. D. Chapman, Br. J. Cancer 54, 453 (1985).
63. J. A. Raleigh, G. G. Miller, A. J. Franko, C. J. Koch, A. F. Fuciarelli, and D. A. Kelley, Br. J. Cancer 56, 395 (1987).
64. R. J. Hodgkiss, G. Jones, A. Long, J. Parrick, K. A. Smith, and M. R. L. Stratford, Br. J. Cancer 63, 119 (1991).
65. R. J. Hodgkiss, M. R. Stratford, M. F. Dennis, and S. A. Hill, Br. J. Cancer 72, 1462 (1995).
66. C. J. Koch, S. M. Evans, and E. M. Lord, Br. J. Cancer 72, 869 (1995).
67. S. M. Evans, W. T. Jenkins, B. Joiner, E. M. Lord, and C. J. Koch, Cancer Res. 56, 405 (1996).
68. E. M. Lord, L. W. Harwell, and C. J. Koch, Cancer Res. 53, 5271 (1993).
69. K. M. Laughlin, S. M. Evans, W. T. Jenkins, M. Tracy, C. Y. Chan, E. M. Lord, and C. J. Koch, J. Pharmacol. Exp. Ther. 277, 1049 (1996).
70. M. R. Woods, E. M. Lord, and C. J. Koch, Int. J. Radiat. Oncol. Biol. Phys. 34, 93 (1996).
71. J. Lee, D. W. Siemann, C. J. Koch, and E. M. Lord, Int. J. Cancer 67, 372 (1996).
72. H. Kajino, Y.-Q. Chen, S. Chemtob, N. Waleh, C. J. Koch, and R. I. Clyman, Am. J. Physiol. Regul. Integr. Comp. Physiol. 279, 278 (2000).
73. S. Bialik, D. L. Geenen, I. Sasson, R. Cheng, J. Horner, S. M. Evans, E. M. Lord, C. J. Koch, and R. N. Kitsis, J. Clin. Invest. 100, 1363 (1997).
74. M. Bergeron, S. M. Evans, F. R. Sharp, C. J. Koch, E. M. Lord, and D. M. Ferriero, Neuroscience 89, 1357 (1999).
75. P. L. Southwick, L. A. Ernst, E. W. Tauriello, S. R. Parker, R. B. Mujumdar, S. R. Mujumdar, H. A. Clever, and A. S. Waggoner, Cytometry 11, 418 (1990).
76. S. M. Evans, S. Hahn, D. R. Pook, W. T. Jenkins, A. A. Chalian, E Zhang, C. Stevens, R. Weber, I. Benjamin, N. Mirza, M. Morgan, S. Rubin, W. G. McKenna, E. M. Lord, and C. J. Koch, Cancer Res. 60, 2018 (2000).
77. T. M. Busch, S. M. Hahn, S. M. Evans, and C. J. Koch, Cancer Res. 60, 2636 (2000).
78. C. N. Coleman, L. Noll, A. E. Howes, J. R. Harris, J. Zakar, and R. A. Kramer, Int. J. Radiat. Oncol. Biol. Phys. 16, 1085 (1989).
79. A. S. Kennedy, J. A. Raleigh, G. M. Perez, D. P. Calkins, D. E. Thrall, D. B. Novotny, and M. Varia, Int. J. Radiat. Oncol. Biol. Phys. 37, 897 (1997).
80. J. T. Roberts, N. M. Bleehen, M. I. Walton, and P. Workman, Br. J. Radiol. 59, 107 (1986).
81. M. I. Saunders, S. Dische, D. Fermont, A. Bishop, I. Lenox-Smith, J. G. Allen, and S. L. Malcolm, Br. J. Cancer 46, 706 (1982).
82. M. I. Walton, N. M. Bleehen, and P. Workman, Biochem. Pharmacol. 34, 3939 (1985).
83. J. S. Rasey, P. D. Hofstrand, L. K. Chin, and T. K. Tewson, J. Nucl. Med. 40, 1072 (1999).
84. C. J. Koch, S. M. Hahn, K. J. Rockwell, J. M. Covey, W. K. McKenna, and S. M. Evans, Cancer Chemother. Pharmacol. 48, 177 (2001).
85. S. M. Evans, S. Hahn, D. R. Pook, P. J. Zhang, W. T. Jenkins, D. Fraker, R. A. Hsi, W. G. McKenna, and C. J. Koch, Int. J. Radiat. Oncol. Biol. Phys. 49, 587 (2000).
86. T. M. Busch, S. M. Hahn, S. M. Eva, C. J. Koch Cancer Res. 60, 2636 (2000).
87. I. M. Shapiro, K. D. Mansfield, S. M. Evans, E. M. Lord, and C. J. Koch, Am. J. Physiol. 272, c1134 (1997).
88. J. D. Chapman, E. L. Engelhardt, C. C. Stobbe, R. F. Schneider, and G. E. Hanks, Radiother. Oncol. 46, 229 (1998).
89. L. L. Wiebe and D. Stypinski, Q. J. Nucl. Med. 40, 270 (1996).
90. S. M. Evans, A. V. Kachur, C.-Y. Shiue, R. Hustinx, W. T. Jenkins, G. G. Shiue, J. S. Karp, A. Alavi, E. M. Lord, W. R. Dolbier, Jr., and C. J. Koch, J. Nucl. Med. 41,327 (1999).